Pharmacological treatment of psychosomatic manifestations in geropsychiatric patients.
D000367:Age Factors; D000368:Aged; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D003863:Depression / Q000188:drug therapy / Q000523:psychology; D005474:Fluoxymesterone / Q000627:therapeutic use; D005852:Geriatric Psychiatry / Q000639:trends; D006801:Humans; D001523:Mental Disorders / Q000453:epidemiology; D008875:Middle Aged; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D011157:Population Dynamics; D011602:Psychophysiologic Disorders / Q000188:drug therapy* / Q000523:psychology; D012649:Self Concept
D014151:Anti-Anxiety Agents; D000929:Antidepressive Agents, Tricyclic; D008996:Monoamine Oxidase Inhibitors; D005474:Fluoxymesterone